BE904152A - Formulation a liberation prolongee contenant des alcaloides de l'ergot de seigle. - Google Patents

Formulation a liberation prolongee contenant des alcaloides de l'ergot de seigle.

Info

Publication number
BE904152A
BE904152A BE1/011431A BE1011431A BE904152A BE 904152 A BE904152 A BE 904152A BE 1/011431 A BE1/011431 A BE 1/011431A BE 1011431 A BE1011431 A BE 1011431A BE 904152 A BE904152 A BE 904152A
Authority
BE
Belgium
Prior art keywords
sustained release
release formulation
formulation containing
ergot alkaloids
containing rye
Prior art date
Application number
BE1/011431A
Other languages
English (en)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858502889A external-priority patent/GB8502889D0/en
Priority claimed from GB858517604A external-priority patent/GB8517604D0/en
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of BE904152A publication Critical patent/BE904152A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Formulation à libération prolongée pour l'administration par voie orale comprenant un alcaloide de l'ergot de seigle 9,10-dihydrogéné, une substance gonflante hydrophile pharmaceutiquement acceptable et une matière grasse inerte pharmaceutiquement acceptable. Cette formulation se présente sous forme d'une dose unitaire, administrable une fois par jour.
BE1/011431A 1985-02-05 1986-02-03 Formulation a liberation prolongee contenant des alcaloides de l'ergot de seigle. BE904152A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858502889A GB8502889D0 (en) 1985-02-05 1985-02-05 Co-dergocrine compositions
GB858517604A GB8517604D0 (en) 1985-07-12 1985-07-12 Dihydroergotamine compositions

Publications (1)

Publication Number Publication Date
BE904152A true BE904152A (fr) 1986-08-04

Family

ID=26288767

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1/011431A BE904152A (fr) 1985-02-05 1986-02-03 Formulation a liberation prolongee contenant des alcaloides de l'ergot de seigle.

Country Status (24)

Country Link
JP (1) JPS61183225A (fr)
KR (1) KR920010388B1 (fr)
AU (1) AU597570B2 (fr)
BE (1) BE904152A (fr)
CA (1) CA1263087A (fr)
CH (1) CH667592A5 (fr)
CY (1) CY1604A (fr)
DE (1) DE3602577A1 (fr)
DK (1) DK167138B1 (fr)
ES (1) ES8800040A1 (fr)
FR (1) FR2576787B1 (fr)
GB (1) GB2170407B (fr)
GR (1) GR860310B (fr)
HK (1) HK57191A (fr)
HU (1) HU195729B (fr)
IE (1) IE59293B1 (fr)
IT (1) IT1191255B (fr)
LU (1) LU86289A1 (fr)
NL (1) NL8600161A (fr)
NZ (1) NZ215020A (fr)
PH (1) PH23384A (fr)
PT (1) PT81954B (fr)
SE (1) SE8600496L (fr)
SG (1) SG56191G (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2610827B1 (fr) * 1987-02-18 1991-09-13 Pf Medicament Comprime de dihydroergotamine (d.h.e.) du type a matrice hydrophile et son procede de fabrication
YU47044B (sh) * 1987-03-11 1994-12-28 LEK TOVARNA FARMACEVTSKIH IN KEMIČNIH IZDELKOV n.sol.o. Postupak za dobijanje tableta sa produženim delovanjem na bazi hidroksipropil-metilceluloze velike molekularne mase
CA2393344C (fr) * 1999-12-03 2009-09-01 Polichem S.A. Procedes permettant la preparation de compositions pharmaceutiques a liberation prolongee d'alcaloides d'ergot presentant une biodisponibilite amelioree et compositions ainsi obtenues
US7771746B2 (en) 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
DE60132444T2 (de) 2000-05-12 2009-01-22 Meracol Corp. Ltd., Takapuna Behandlung von reizkolon-syndrom oder -krankheit
ATE381327T1 (de) * 2000-05-12 2008-01-15 Meracol Corp Ltd Cethylmyristat und cetylpalmitat zurbehandlung von ekzemen und/oder psoriasis
NZ504526A (en) * 2000-05-12 2003-05-30 Meracol Corp Ltd Treating herpes simplex symptoms using a mixture of cetyl myristate and cetyl palmitate
US20030153620A1 (en) 2000-05-12 2003-08-14 Meakin Timothy David Treating eczema and/or psoriasis
WO2003026640A1 (fr) * 2001-09-28 2003-04-03 Meracol Corporation Limited Traitement d'allergies alimentaires et/ou d'intolerances alimentaires
CN111297815B (zh) * 2020-04-29 2022-04-15 宝利化（南京）制药有限公司 一种甲磺酸二氢麦角碱缓释片及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3147187A (en) * 1962-09-10 1964-09-01 Don Hall Lab Sustained release pharmaceutical
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
DE3124983A1 (de) * 1981-06-25 1983-01-20 Meditest Inst Fuer Medizinisch Arzneiformen zur oralen verabreichung
CH649300A5 (de) * 1981-08-07 1985-05-15 Sandoz Ag Ergopeptinderivate, ihre herstellung und verwendung.
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
DE3303616A1 (de) * 1982-02-12 1983-08-25 Sandoz-Patent-GmbH, 7850 Lörrach Mutterkornalkaloide, verfahren zu deren herstellung sowie diese verbindungen enthaltende pharmazeutische zubereitungen
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
JPS604120A (ja) * 1983-06-22 1985-01-10 Shionogi & Co Ltd 作用持続型ピナシジル製剤
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
GB8413795D0 (en) * 1984-05-30 1984-07-04 Sandoz Ltd Organic compounds

Also Published As

Publication number Publication date
DK52086D0 (da) 1986-02-03
HUT41984A (en) 1987-06-29
HK57191A (en) 1991-08-02
FR2576787A1 (fr) 1986-08-08
GR860310B (en) 1986-05-27
IT8647620A0 (it) 1986-02-05
GB2170407A (en) 1986-08-06
GB2170407B (en) 1988-10-26
NZ215020A (en) 1989-07-27
JPS61183225A (ja) 1986-08-15
DK167138B1 (da) 1993-09-06
PT81954B (pt) 1988-07-01
LU86289A1 (fr) 1986-09-02
CH667592A5 (de) 1988-10-31
ES8800040A1 (es) 1987-10-16
DE3602577A1 (de) 1986-08-28
NL8600161A (nl) 1986-09-01
PT81954A (en) 1986-03-01
SE8600496D0 (sv) 1986-02-04
AU597570B2 (en) 1990-06-07
SE8600496L (sv) 1986-08-06
AU5294286A (en) 1986-08-14
IT1191255B (it) 1988-02-24
HU195729B (en) 1988-07-28
DK52086A (da) 1986-08-06
KR920010388B1 (ko) 1992-11-27
IE59293B1 (en) 1994-02-09
FR2576787B1 (fr) 1990-01-12
IE860291L (en) 1986-08-05
PH23384A (en) 1989-07-26
ES551635A0 (es) 1987-10-16
GB8602602D0 (en) 1986-03-12
SG56191G (en) 1991-08-23
CY1604A (en) 1992-04-03
CA1263087A (fr) 1989-11-21
KR860006265A (ko) 1986-09-09

Similar Documents

Publication Publication Date Title
IL96900A0 (en) Pharmaceutical composition containing naproxen
RU2000111506A (ru) Таблетки с пролонгированным выделением для лечения болезни паркинсона
FR2673538B1 (fr) Composition a base de 3-[2-(dimethylamino)ethyl]-n-methyl-1h-indole-5 methanesulfonamide pour l'administration buccale.
IL111519A (en) Sustained release tablets containing acetaminophen and methods for the preparation thereof
NO883667D0 (no) Kapsel for farmasoeytisk virksomme innholdsstoffer av en droge.
IL91656A0 (en) Pharmaceutical composition containing a benzodiazepine derivative
PT862396E (pt) Aneis intravaginais com nucleo inserivel contendo farmaco
NO166448C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindioner.
MY125662A (en) Pharmaceutical formulations containing darifenacin
NL970006I1 (nl) Gebruik van indolon-derivaten voor het bereiden van geneesmiddelen ter behandeling van de ziekte vanParkinson.
BE896205A (fr) Nouvelles formulations pharmaceutiques contenant le coenzyme q10 adaptees pour l'administration topique
MY100998A (en) Pharmaceutical formulations
EP1004315A4 (fr) Preventifs et/ou medicaments contre le lupus erythemateux systemique, contenant un anticorps anti-recepteur d'il-6 comme ingredient actif
KR880007074A (ko) 의약품
KR880007073A (ko) 의 약 품
IE821489L (en) Pharmaceutical formulations
MY124465A (en) Reduction of infarct volume using citicoline
FR2660192B1 (fr) Formulation liposomiales pour l'administration topique ou vaginale de medicaments.
ZA828639B (en) Novel triazoloquinazolinones, their preparation and pharmaceutical formulations containing these compounds
KR860006265A (ko) 9,10-디하이드로 에르고트 알카로이드를 함유하는 서방성 제재의 제조방법
FR2444463A1 (fr) Nouvelles compositions pharmaceutiques solides a base d'alcaloides de l'ergot de seigle, permettant une liberation controlee de ce principe actif
NO307496B1 (no) Anvendelse av en <delta>-opioid antagonist for fremstilling av et antitussivt middel
FR2587213A1 (fr) Medicament pour le traitement de la dependance aux psychostimulants
US4122177A (en) Method of treating oligospermia and asthenospermia
GB1535778A (en) Compounds useful in treatment of unipolar depression

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SANDOZ S.A.

Effective date: 19940228